Annelie Falkevall and her co-workers showed that modulating the signalling pathway that controls lipid accumulation in the kidneys might be a possible strategy to treat diabetic kidney disease. Quantification of specific lipids by lipidomics analyses done at the Swedish Metabolomics Centre supported their studies.
See the article here:
Falkevall et al., Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease, Cell Metabolism, Volume 25, Issue 3, 7 March 2017, Pages 713-726, ISSN 1550-4131
Lipid quantification supports research on diabetic kidney disease